DK80989A - Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af laegemidler - Google Patents

Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af laegemidler

Info

Publication number: DK80989A
Authority: DK; Denmark
Prior art keywords: derivatives; quinolizinon; quinolizin; preparation; medicinal products
Prior art date: 1988-02-23

Application number

DK080989A

Other languages

English (en)

Other versions

DK80989D0 (da

DK175643B1 (da

Inventor

Maurice W Gittos

Francis P Miller

Stephen M Sorensen

John R Fozard

Paul Moser

Michael G Palfreyman

Hsien C Cheng

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-02-23

Filing date

1989-02-22

Publication date

1989-08-24

1988-02-23 Priority claimed from EP88400416A external-priority patent/EP0329903A1/en

1988-02-23 Priority claimed from EP88400415A external-priority patent/EP0329902A1/en

1988-02-23 Priority claimed from EP88400418A external-priority patent/EP0329905A1/en

1988-02-23 Priority claimed from EP88400417A external-priority patent/EP0329904A1/en

1989-02-22 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1989-02-22 Publication of DK80989D0 publication Critical patent/DK80989D0/da

1989-08-24 Publication of DK80989A publication Critical patent/DK80989A/da

2005-01-03 Application granted granted Critical

2005-01-03 Publication of DK175643B1 publication Critical patent/DK175643B1/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Nutrition Science (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK198900809A 1988-02-23 1989-02-22 Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af lægemidler DK175643B1 (da)

Applications Claiming Priority (10)

Application Number	Priority Date	Filing Date	Title
EP88400416A EP0329903A1 (en)	1988-02-23	1988-02-23	Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma
EP88400415A EP0329902A1 (en)	1988-02-23	1988-02-23	Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of psychosis
EP88400417		1988-02-23
EP88400415		1988-02-23
EP88400418		1988-02-23
EP88400418A EP0329905A1 (en)	1988-02-23	1988-02-23	Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility
EP88400416		1988-02-23
EP88400417A EP0329904A1 (en)	1988-02-23	1988-02-23	Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety
US18563188A	1988-04-26	1988-04-26
US18563188		1988-04-26

Publications (3)

Publication Number	Publication Date
DK80989D0 DK80989D0 (da)	1989-02-22
DK80989A true DK80989A (da)	1989-08-24
DK175643B1 DK175643B1 (da)	2005-01-03

Family

ID=27513624

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198900809A DK175643B1 (da)	1988-02-23	1989-02-22	Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af lægemidler

Country Status (10)

Country	Link
EP (1)	EP0329932B1 (da)
JP (1)	JPH02288880A (da)
KR (1)	KR890013018A (da)
AT (1)	ATE129153T1 (da)
AU (1)	AU624115B2 (da)
DE (1)	DE68924545T2 (da)
DK (1)	DK175643B1 (da)
ES (1)	ES2080727T3 (da)
GR (1)	GR3018299T3 (da)
IE (1)	IE72504B1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE97803T1 (de) *	1989-04-21	1993-12-15	Sandoz Ag	Therapeutische verwendung von 5-ht3-rezeptorantagonisten.
EP0492020A1 (en) *	1990-12-21	1992-07-01	Merrell Dow Pharmaceuticals Inc.	Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
AU675060B2 (en) *	1992-02-24	1997-01-23	Aventisub Ii Inc.	2,6-methano-2H-quinolizin derivative as 5-HT3-receptor antagonist
US5508287A (en) *	1992-02-24	1996-04-16	Merrell Pharmaceuticals Inc.	2,6-methano-2H-quinolizin derivative as 5-HT3 -receptor antagonist
ES2363998T3 (es) *	2007-03-23	2011-08-22	Abbott Laboratories	Derivados ester y carbamato de azaadamantano y métodos de uso de los mismos.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI74707C (fi) *	1982-06-29	1988-03-10	Sandoz Ag	Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
WO1985001048A1 (en) *	1983-08-26	1985-03-14	Sandoz Ag	Aromatic esters or amides of carboxylic acid and sulfonic acid
DE3445377A1 (de) *	1983-12-23	1985-07-04	Sandoz-Patent-GmbH, 7850 Lörrach	Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen
AU583343B2 (en) *	1985-01-23	1989-04-27	Glaxo Group Limited	Heterocyclic compounds
DE385517T1 (de) *	1985-03-14	1991-07-25	Beecham Group p.l.c., Brentford, Middlesex	Arzneimittel zur behandlung von erbrechen.
GB8525913D0 (en) *	1985-10-21	1985-11-27	Beecham Group Plc	Compounds
GB8511988D0 (en) *	1985-05-11	1985-06-19	Beecham Group Plc	Compounds
GB8520616D0 (en) *	1985-08-16	1985-09-25	Beecham Group Plc	Compounds
GB8523211D0 (en) *	1985-09-19	1985-10-23	Beecham Group Plc	Compounds
EP0220011A3 (en) *	1985-10-12	1990-01-03	Beecham Group Plc	Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
US4910193A (en) *	1985-12-16	1990-03-20	Sandoz Ltd.	Treatment of gastrointestinal disorders
ZA878096B (en) *	1986-11-03	1988-04-26	Merrell Dow Pharmaceuticals Inc.	Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds
EP0330788A1 (en) *	1988-03-01	1989-09-06	Merrell Dow Pharmaceuticals Inc.	Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia

1989
- 1989-01-11 EP EP89100392A patent/EP0329932B1/en not_active Expired - Lifetime
- 1989-01-11 DE DE68924545T patent/DE68924545T2/de not_active Expired - Lifetime
- 1989-01-11 ES ES89100392T patent/ES2080727T3/es not_active Expired - Lifetime
- 1989-01-11 AT AT89100392T patent/ATE129153T1/de not_active IP Right Cessation
- 1989-02-22 KR KR1019890002061A patent/KR890013018A/ko not_active Ceased
- 1989-02-22 DK DK198900809A patent/DK175643B1/da not_active IP Right Cessation
- 1989-02-22 IE IE56489A patent/IE72504B1/en not_active IP Right Cessation
- 1989-02-22 AU AU30214/89A patent/AU624115B2/en not_active Expired
- 1989-02-23 JP JP1042012A patent/JPH02288880A/ja active Pending
1995
- 1995-12-05 GR GR950403417T patent/GR3018299T3/el unknown

Also Published As

Publication number	Publication date
DE68924545T2 (de)	1996-03-21
EP0329932B1 (en)	1995-10-18
AU3021489A (en)	1989-08-24
KR890013018A (ko)	1989-09-20
DK80989D0 (da)	1989-02-22
ATE129153T1 (de)	1995-11-15
EP0329932A2 (en)	1989-08-30
IE72504B1 (en)	1997-04-23
EP0329932A3 (en)	1992-08-05
DK175643B1 (da)	2005-01-03
AU624115B2 (en)	1992-06-04
GR3018299T3 (en)	1996-03-31
JPH02288880A (ja)	1990-11-28
ES2080727T3 (es)	1996-02-16
IE890564L (en)	1989-08-23
DE68924545D1 (de)	1995-11-23

Similar Documents

Publication	Publication Date	Title
HUT49113A (en)	1989-08-28	Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
NO875378D0 (no)	1987-12-22	Fremgangsmaate for fremstilling av grannlocyttstimulerende faktor (polypeptidderivater).
DE3585185D1 (de)	1992-02-27	Immunogene konjugate der lt-b enterotoxinuntereinheit von e. coli und kapselige polymere.
NO172344C (no)	1993-07-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter
NO166362C (no)	1991-07-10	Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
DK217588A (da)	1988-10-23	17beta-(cyclopropylamino)-androst-5-en-3beta-olderivater, deres fremstilling og anvendelse som laegemidler
DK336688D0 (da)	1988-06-20	Nucleosider od fremgangsmaade til fremstilling deraf
ATE65402T1 (de)	1991-08-15	Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
GR3001559T3 (en)	1992-11-23	Polyoxygenated labdane derivatives, process for their preparation and their use as medicaments
FI93106C (fi)	1995-02-27	Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
DK80989D0 (da)	1989-02-22	Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af laegemidler
DE3681581D1 (de)	1991-10-24	4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamine und 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamine.
FI895983A0 (fi)	1989-12-14	Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
DK557189A (da)	1990-05-30	1,2,3,4-tetrahydro-1,9-acridindiaminer, deres fremstilling og anvendelse som laegemidler
NO171211C (no)	1993-02-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
DK429788A (da)	1989-03-30	Thieno(2,3-beta)thiophen-2-sulfonamid og farmaceutisk praeparat indeholdende en saadan forbindelse
FR2530246B1 (fr)	1985-06-14	Nouveaux derives pyrido indoliniques et pirido indoliques et leurs sels, ainsi que le procede de preparation et l'application en therapeutique de ces derives et sels
FI97884B (fi)	1996-11-29	Menetelmä uusien terapeuttisesti käyttökelpoisten 3,4-dihydroksi-2,5-dihydrofuranonien valmistamiseksi
FI904229A0 (fi)	1990-08-27	Cytotoxisk faktor foer oligodendrocyter.
PT86695A (pt)	1988-03-01	Process for the preparation of tetrahydropyridoý3',4':4,5¨pyrr oloý2,3-c¨quinolines and their derivatives
FI893570A7 (fi)	1990-01-27	Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
PT87821A (pt)	1989-05-31	Process for the preparation of 10-propyl-2,8-bis(1h-tetrazol-5-il)-4h,6h-benzo(1,2-b;5,4-b)dypiran-4,6-dione of calcium
HUT58742A (en)	1992-03-30	Process for producing alpha-adrenerg-receptor antagonistic thieno-benzazepines and pharmaceutical compositions containing them
NO170331C (no)	1992-10-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive acyleringsprodukter av bis(2-imidazolin-2-ylhydrazoner)av 9,10-antracen- dikarboksaldehyd
ES2013877A6 (es)	1990-06-01	Nuevo procedimiento para producir derivados de imidazopiridina.

Legal Events

Date	Code	Title	Description
2009-03-09	PUP	Patent expired